Table 3. HRs for CRC-specific mortality among patients with colorectal cancer by quintile of post-diagnosis dietary insulin index stratified by predictors of patient outcome.
Dietary insulin index |
|||||||
---|---|---|---|---|---|---|---|
Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 | ||||
Stratification covariate | No. of patients | Quintile 1 | HR (95% CI)a | HR (95% CI)a | HR (95% CI)a | HR (95% CI)a | Pinteraction |
Age at diagnosis, yearsb | 0.56 | ||||||
⩽67 | 999 | Referent | 1.39 (0.84–2.29) | 1.50 (0.91–2.47) | 1.92 (1.16–3.17) | 1.79 (1.04–3.07) | |
>67 | 1007 | Referent | 0.90 (0.49–1.67) | 1.09 (0.61–1.96) | 1.24 (0.71–2.18) | 1.44 (0.82–2.54) | |
Sex | 1.00 | ||||||
Female | 1314 | Referent | 0.99 (0.62–1.58) | 1.24 (0.78–1.95) | 1.53 (0.97–2.42) | 1.58 (0.98–2.54) | |
Male | 692 | Referent | 1.70 (0.86–3.37) | 1.50 (0.74–3.02) | 1.73 (0.89–3.39) | 1.81 (0.89–3.67) | |
BMI, kg m−2 | 0.01 | ||||||
<25.0 | 890 | Referent | 1.13 (0.69–1.85) | 0.80 (0.47–1.35) | 0.97 (0.57–1.63) | 1.14 (0.67–1.93) | |
⩾25.0 | 966 | Referent | 1.10 (0.55–2.22) | 2.24 (1.21–4.14) | 2.93 (1.59–5.40) | 2.32 (1.21–4.46) | |
Physical activity, MET-h per weekb | 0.40 | ||||||
⩽10.2 | 917 | Referent | 1.47 (0.80–2.68) | 1.84 (1.02–3.31) | 2.28 (1.29–4.02) | 2.37 (1.30–4.30) | |
>10.2 | 908 | Referent | 1.07 (0.57–2.00) | 0.98 (0.53–1.82) | 1.04 (0.55–1.97) | 1.47 (0.79–2.72) | |
Alcohol intake, g d−1b | 0.38 | ||||||
⩽1.9 | 1011 | Referent | 0.76 (0.40–1.43) | 0.88 (0.47–1.62) | 1.09 (0.61–1.95) | 1.01 (0.56–1.82) | |
>1.9 | 995 | Referent | 1.32 (0.82–2.13) | 1.45 (0.90–2.33) | 1.63 (0.99–2.69) | 2.26 (1.34–3.81) | |
Diagnosis periodb | 0.82 | ||||||
1976–1997 | 1056 | Referent | 1.30 (0.78–2.16) | 1.28 (0.77–2.11) | 2.02 (1.24–3.31) | 1.60 (0.94–2.72) | |
1998–2010 | 950 | Referent | 0.99 (0.54–1.82) | 1.53 (0.85–2.76) | 0.96 (0.52–1.79) | 1.72 (0.97–3.07) | |
Time between diagnosis and dietary assessment, years | 0.14 | ||||||
0<2 | 1105 | Referent | 1.15 (0.72–1.83) | 1.52 (0.96–2.43) | 1.54 (0.98–2.43) | 2.11 (1.33–3.37) | |
2–4 | 901 | Referent | 1.21 (0.61–2.41) | 1.17 (0.61–2.24) | 1.68 (0.86–3.27) | 1.05 (0.51–2.18) | |
Stage | 1.00 | ||||||
I/II | 1204 | Referent | 1.44 (0.71–2.88) | 1.83 (0.92–3.63) | 2.12 (1.09–4.12) | 1.63 (0.80–3.34) | |
III/IV | 573 | Referent | 1.21 (0.73–2.00) | 1.17 (0.71–1.92) | 1.38 (0.83–2.29) | 1.73 (1.05–2.83) | |
Grade of tumour differentiation | 0.17 | ||||||
Well/moderate | 1416 | Referent | 1.15 (0.69–1.92) | 1.63 (1.01–2.63) | 1.81 (1.12–2.92) | 2.05 (1.24–3.39) | |
Poor | 265 | Referent | 1.62 (0.76–3.42) | 1.09 (0.51–2.37) | 0.97 (0.42–2.25) | 1.09 (0.43–2.74) | |
Location of primary tumour | 0.75 | ||||||
Colon | 1467 | Referent | 1.33 (0.82–2.17) | 1.56 (0.98–2.50) | 1.82 (1.14–2.90) | 1.79 (1.09–2.92) | |
Rectum | 444 | Referent | 0.87 (0.44–1.73) | 0.88 (0.42–1.80) | 1.14 (0.57–2.27) | 1.35 (0.67–2.72) |
Abbreviations: BMI=body mass index; CI=confidence interval; CRC=colorectal cancer; HR=hazard ratio; MET=metabolic equivalent.
Adjusted for age at diagnosis (continuous), sex, race (White, Black, other, unknown), smoking status (never, past, current, unknown), body mass index (<18.5, 18.5–24.9, 25.0–29.9, 30.0–34.9, ⩾35.0 kg m−2, or unknown), physical activity (quintiles or unknown), alcohol intake (0, 0.1–4.9, 5.0–14.9, ⩾15.0 g d−2), cancer stage (I–IV or unknown), grade of tumour differentiation (well, moderate, poor, unknown), location of primary tumour (proximal, distal, rectum, unknown) and year of diagnosis (continuous), excluding the stratification covariate.
Cutpoints chosen based on median values.